Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres.
Eur Respir J
; 60(1)2022 07.
Article
in En
| MEDLINE
| ID: mdl-35618274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lung Transplantation
/
COVID-19
/
Antibodies, Monoclonal
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Eur Respir J
Year:
2022
Document type:
Article
Affiliation country:
Germany